- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 239/94 - Nitrogen atoms
Patent holdings for IPC class C07D 239/94
Total number of patents in this class: 721
10-year publication summary
55
|
54
|
46
|
41
|
46
|
54
|
30
|
64
|
48
|
13
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Araxes Pharma LLC | 91 |
18 |
Boehringer Ingelheim International GmbH | 4629 |
15 |
The Regents of the University of California | 18943 |
14 |
NATCO Pharma Limited | 197 |
13 |
Gilead Sciences, Inc. | 1879 |
10 |
Bristol-myers Squibb Company | 5080 |
9 |
Genentech, Inc. | 3742 |
8 |
Janssen Pharmaceutica N.V. | 3839 |
7 |
Vertex Pharmaceuticals Incorporated | 1581 |
7 |
Array BioPharma Inc. | 551 |
7 |
Chiesi Farmaceutici S.p.A. | 940 |
7 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 156 |
7 |
Merck Patent GmbH | 5909 |
6 |
The Trustees of Columbia University in the City of New York | 3440 |
6 |
Northwestern University | 3112 |
6 |
Asana Biosciences, LLC | 42 |
6 |
Council of Scientific & Industrial Research | 1397 |
6 |
Dana-Farber Cancer Institute, Inc. | 2455 |
6 |
Evotec International GmbH | 76 |
6 |
Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
Other owners | 551 |